Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA matching in allogeneic stem cell transplantation.

Effie W Petersdorf1

  • 1University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Division of Clinical Research, Seattle, Washington 98109, USA. epetersd@fhcrc.org

Current Opinion in Hematology
|November 19, 2004
PubMed
Summary

Optimizing unrelated hematopoietic cell transplantation (HCT) relies on human leukocyte antigen (HLA) compatibility. Precise HLA matching between donor and patient reduces post-transplant complications and improves survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended HLA Haplotypes and Transplant Survival.

Blood·2026
Same author

Nomenclature for Factors of the HLA System, 2026.

HLA·2026
Same author

Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation.

Transplantation and cellular therapy·2025
Same author

HLAtools, Searching Shared HLA Amino Acid Residue Prevalence, and the Global Frequency Browsers: New Computational Resources for Working With HLA Data and Visualizing Global Patterns of HLA Variation.

International journal of immunogenetics·2025
Same author

Semper Progrediens.

Transplantation and cellular therapy·2025

Area of Science:

  • Immunogenetics
  • Hematopoietic Cell Transplantation (HCT)

Background:

  • Human leukocyte antigen (HLA) compatibility is crucial for successful unrelated HCT.
  • HLA mismatches increase risks of graft rejection, graft-versus-host disease, and mortality.

Purpose of the Study:

  • To review recent advancements in immunogenetics for unrelated HCT.
  • Focus on myeloablative conditioning regimens and HLA matching.

Main Methods:

  • Utilizing molecular typing to identify HLA class I and II alleles.
  • Exploring functional assays to determine permissible HLA mismatches.

Main Results:

  • Molecular typing accurately discriminates HLA alleles.
  • Increased HLA mismatches correlate with higher post-transplant complication rates.

Related Experiment Videos

  • Nongenetic factors also impact HCT outcomes.

    • Conclusions:

    • HLA alleles are functionally significant in HCT.
    • Comprehensive HLA matching optimizes unrelated HCT success.
    • Single HLA mismatches may be acceptable for high-risk patients lacking matched donors.